Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0015695 (
fatty liver
)
13,941
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Choline is an essential nutrient for all living cells and is produced extracellularly by sequential degradation of phosphatidylcholine (PC). However, little is known about how choline is produced extracellularly. Here, we report that
ENPP6
, a choline-specific phosphodiesterase, hydrolyzes glycerophosphocholine (GPC), a degradation product of PC, as a physiological substrate and participates in choline metabolism.
ENPP6
is highly expressed in liver sinusoidal endothelial cells and developing oligodendrocytes, which actively incorporate choline and synthesize PC.
ENPP6
-deficient mice exhibited
fatty liver
and hypomyelination, well known choline-deficient phenotypes. The choline moiety of GPC was incorporated into PC in an
ENPP6
-dependent manner both in vivo and in vitro. The crystal structure of
ENPP6
in complex with phosphocholine revealed that the choline moiety of the phosphocholine is recognized by a choline-binding pocket formed by conserved aromatic and acidic residues. The present study provides the molecular basis for
ENPP6
-mediated choline metabolism at atomic, cellular and tissue levels.
...
PMID:Structure and biological function of ENPP6, a choline-specific glycerophosphodiester-phosphodiesterase. 2688 14